Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $19.2 million versus the consensus estimate of $17.76 million.

GUIDANCE:

Apyx Medical Corp. sees FY2026 revenue of $57.5-58.5 million, versus the consensus of $56.05 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.